Cereno Scientific AB

Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.

CRNO | ST

Overview

Corporate Details

ISIN(s):: SE0008241541 (+3 more)
LEI:: 549300VX8KTMYDS6NM84
Country:: Sweden
Address:: BioVentureHub, 431 83 Mölndal
Website:: https://cerenoscientific.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Cereno Scientific AB is a clinical-stage biotechnology company focused on developing innovative, disease-modifying treatments for rare cardiovascular and pulmonary diseases. The company's pipeline includes drug candidates in both clinical and preclinical phases. Its clinical portfolio utilizes epigenetic modulation through an HDACi (histone deacetylase inhibitor) platform. A key preclinical asset, CS585, is a novel prostacyclin (IP) receptor agonist. Cereno's strategy targets diseases with significant unmet medical needs, aiming to provide high treatment value to patients while leveraging a business model that allows for potentially shorter development timelines and accelerated market entry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cereno Scientific AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cereno Scientific AB

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Cereno Scientific AB via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
2025-04-16	Sten Sörensen	Other	Other	866,665	86,666.50 SEK
2024-11-25	Security Holding Sverige AB	Other	Buy	20,000	99,800.00 SEK

Peer Companies

Company	Country	Ticker
Delta-Fly Pharma, Inc. Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.	Japan	4598
DENTSU GROUP INC. Global advertising & marketing firm integrating tech and consulting for brand growth.	Japan	4324
DGA S.A. Consulting, training, and EU-funded project services for public and private organizations.	Poland	DGA
DIGITAL HOLDINGS,INC. Drives business DX with data-driven advertising, CRM consulting, and AI integration.	Japan	2389
DIGITALIFT Inc. Digital marketing firm providing programmatic ad operations and strategic consulting services.	Japan	9244
D.L.S.I. HR and recruitment services for temp, fixed-term, and permanent roles across industries.	France	ALDLS
Doric Nimrod Air Three Limited Investment firm leasing four Airbus A380s to Emirates for shareholder returns.	Guernsey	N/A
DP Aircraft I Limited Acquires, leases, and sells Boeing 787-8 aircraft to commercial airlines for investors.	Guernsey	N/A
DreamCIS INC. A CRO providing clinical research services for pharma, biotech, and medical device industries.	South Korea	223250
DT&CRO CO., Ltd. A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.	South Korea	383930